Relay Therapeutics, Inc. · NASDAQ:RLAY
Catinazzo Thomas sold 187,163 Relay Therapeutics, Inc. shares (Form 4)
Traded Jun 22, 2026 · Filed Jun 24, 2026
On Jun 22, 2026, Catinazzo Thomas (Chief Financial Officer) sold 187,163 Relay Therapeutics, Inc. shares at an average US$16.97 for US$3.18M under a trading plan, leaving 177,461 shares. Filed Jun 24, 2026 (Form 4).
- Sold
- 187,163 shares
- Price
- US$16.97 average (US$16.97 to US$17.01)
- Value
- US$3.18M
- Holding after
- 177,461 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 22, 2026 | Common Stock | Sale | 17,717 | US$17.01 | 177,461 | Direct |
| Jun 22, 2026 | Common Stock | Option exercise | 56,323 | US$5.04 | 233,784 | Direct |
| Jun 22, 2026 | Common Stock | Sale | 56,323 | US$16.97 | 177,461 | Direct |
| Jun 22, 2026 | Common Stock | Option exercise | 61,563 | US$5.22 | 239,024 | Direct |
| Jun 22, 2026 | Common Stock | Sale | 61,563 | US$16.97 | 177,461 | Direct |
| Jun 22, 2026 | Common Stock | Option exercise | 51,560 | US$4.45 | 229,021 | Direct |
| Jun 22, 2026 | Common Stock | Sale | 51,560 | US$16.97 | 177,461 | Direct |
Source
Related
- Relay Therapeutics, Inc.
- Catinazzo Thomas
- Relay Therapeutics, Inc. shareholders
- Form 4 · Catinazzo Thomas · Oct 8, 2026
- Form 4 · Catinazzo Thomas · Sep 9, 2026
- Form 4 · Catinazzo Thomas · Aug 18, 2026
- Form 4 · Catinazzo Thomas · Jul 30, 2026
- Form 4 · Catinazzo Thomas · Jul 8, 2026
- Form 4 · Patel Sanjiv · Oct 8, 2026
- Form 4 · Bergstrom Donald A · Sep 9, 2026
- Form 4 · Patel Sanjiv · Sep 9, 2026
- Form 4 · Rahmer Peter · Aug 28, 2026
- Form 4 · Sb Investment Advisers (UK) LTD · Aug 28, 2026